SOCIETY OF RADIOPHARMACEUTICAL SCIENCES (EIN 431217508) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2008

Legal Domicile

Principal Officer

CHARLES METZGER

Phone

8303706554

Tax Period

2023-01-01 to 2023-12-31

SOCIETY OF RADIOPHARMACEUTICAL SCIENCES, founded in 2008, is a small nonprofit that reported $791K in total revenue in fiscal year 2023. Expenses of $684K left a modest 14% surplus.

Mission

THE SOCIETY IS A MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION DEDICATED TO THE ADVANCEMENT OF EXCELLENCE IN EDUCATION AND RESEARCH IN RADIOPHARMACEUTICAL SCIENCE AND IN THE STUDY AND USE OF RADIOPHARMACEUTICALS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $120,858

Program Service Revenue $659,115

Investment Income $11,454

Other Revenue $0

TOTAL REVENUE $791,427

Expense Breakdown

Grants Paid $78,951

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $635,947

Other Expenses $604,722

TOTAL EXPENSES $683,673

Year-over-Year Comparison

	2023	2022	Change
Revenue	$791,427	$749,461	+0.1%
Expenses	$683,673	$625,697	+0.1%
Net Income	$107,754	$123,764	-0.1%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
FAN WANG PHD	DIRECTOR	1.00	Director	$0	$0	$0
JONATHAN ENGLE PHD	DIRECTOR	1.00	Director	$0	$0	$0
SHOZO FURUMOTO PHD	DIRECTOR	1.00	Director	$0	$0	$0
GIANCARLO PASCALI	DIRECTOR	1.00	Director	$0	$0	$0
ANU AIRAKSINEN PHD	DIRECTOR	1.00	Director	$0	$0	$0
GUY BORMANS PHD	DIRECTOR	1.00	Director	$0	$0	$0
VARENA PICHLER PHD	DIRECTOR	1.00	Director	$0	$0	$0
JENNIFER MURPHY PHD	DIRECTOR	1.00	Director	$0	$0	$0
CATERINA RAMOGIDA PHD	DIRECTOR	1.00	Director	$0	$0	$0
ROGER SCHIBLI PHD	DIRECTOR	1.00	Director	$0	$0	$0
FRANKLIN AIGBIRHIO PHD	DIRECTOR	1.00	Director	$0	$0	$0
FRANK WUESTE PHD	DIRECTOR (AT LARGE)	1.00	Officer Director	$0	$0	$0
CHARLES METZGER	EXECUTIVE DIRECTOR	1.00	Officer Director	$0	$0	$0
JASON LEWIS PHD	IMMEDIATE PAST PRESIDENT	2.00	Officer Director	$0	$0	$0
YUJI KUGE PHD	PRESIDENT	2.00	Officer Director	$0	$0	$0
DANIELLE VUGTS PHD	PRESIDENT ELECT	2.00	Officer Director	$0	$0	$0
PETER SCOTT PHD	TREASURER/SECRETARY	2.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$791,427	$683,673	$586,801	$107,754
2022	$749,461	$625,697	$479,047	$123,764
2021	$206,794	$264,795	$355,283	$-58,001
2020	$70,092	$100,902	$413,284	$-30,810
2019	$666,837	$596,033	$444,094	$70,804
2018	$316,870	$185,737	$373,290	$131,133

SOCIETY OF RADIOPHARMACEUTICAL SCIENCES